trending Market Intelligence /marketintelligence/en/news-insights/trending/S_sLNryjNHCqUobk1hlfbg2 content esgSubNav
In This List

Medtronic's neurosurgery guidance system receives US FDA clearance

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Medtronic's neurosurgery guidance system receives US FDA clearance

The U.S. Food and Drug Administration has cleared Medtronic PLC's Stealth Autoguide system, a robotic surgery platform that provides positioning assistance during neurosurgical procedures.

Medtronic's robotic platform helps surgeons prepare and carry out precise procedures as part of the company's Surgical Synergy platform.

Dublin-based Medtronic develops device-based medical therapies.